Wall Street does not tolerate non-performance. GILD hit hard with 8.5% drop yesterday despite its incredibly low p/e. This mgmt doesn't get it!
Why the big sell off?
$900 per pill is less than sovaldi/harvoni. I'm sure someone will still complain as they want them to give it away!
Read the Street article says they took the low road by pricing lower than earlier drugs.
Gilead set the sticker price for the newly approved hepatitis C drug Epclusa at $74,760 for a 12 week course of treatment.
Should see some window dressing for 3rd Q as well. AMZN may be a candidate. Not so sure if AAPL will see much action since its been a big drip the whole year.
sorry, my bag. meant the 200 sma on the sp500. just hard to fathom that we fell that hard last 2 sessions.
watch 2020 on sp500. 50 sma Brexit was totally overdone but it cleaned the slate for new quarter. no more bellyaching about the s&p being over-valued I'd think.
BWLD very expensive restaurant stock. who'd have thought!
I don't think UK too impacted with immigration as is Germany but certainly plays a role. I think more impacted with neighboring countries like Italy/Greece/Portugal not pulling weight, I can't say I blame them,
I know this is crazy but it makes one wonder about the credibility of these analysts and their so-called price targets! Biotech companies are one of the few sectors that are making money in this economy. This political yo-yo game is well over-played. I keep waiting for some reasoning but have yet to see it.